What is Delirium?
By
Christina Aggar
| April 21st, 2023
Delirium is a sudden decline in a person’s usual mental function. It occurs when signals in the brain aren’t sending and receiving properly, causing…
In Alzheimer’s, Hallucinations Signal Faster Cognitive Decline
By
Simon Spichak, MSc
| April 5th, 2023
As many as one in three people with Alzheimer’s disease experience hallucinations: They see, hear, smell or otherwise sense things that aren’t actually there….
After the ICU, Lower Income Means Higher Risk of Cognitive Decline
By
Nicholas Chan
| March 29th, 2022
Over the last few decades, the number of older adults admitted to the intensive care unit (ICU) has been rising — a trend that…
Every Deep-Drawn Breath: Dementia After the ICU
By
Nicholas Chan
| December 8th, 2021
Dr. E. Wesley Ely discusses the frequency with which intensive care unit survivors go on to experience symptoms of brain dysfunction and dementia, mental…
Pimavanserin Snag: FDA Rejects Acadia’s Dementia Psychosis Drug
By
Alexandra Marvar
| April 5th, 2021
Acadia Pharmaceuticals said today that it has received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration regarding its supplemental New…
Managing the Behavioral Symptoms of Dementia: A BrainTalk With Dr. Dylan Wint
By
Nicholas Chan
| February 15th, 2021
The behavioral changes associated dementia can be some of the most difficult symptoms to cope with. Compounding the challenge, a number of the drugs…
Living Well With Dementia: 3 Things You Need To Know
By
Nicholas Chan
| February 4th, 2021
From coping with cognitive and physical impairments, to behavioral and psychological symptoms, people struggle to adjust to the progressive and unpredictable nature of dementia….
Now Under FDA Review: Potential First Treatment for Dementia-Related Psychosis
By
Nicholas Chan
| January 18th, 2021
Roughly 2.4 million Americans experience symptoms of dementia-related psychosis, ranging from visual and auditory hallucinations, to paranoid delusions and mistrust of loved ones. While…
The Physical Toll of COVID-19 Is Compounded By Its Psychological Impacts
By
Nicholas Chan
| August 3rd, 2020
The public health repercussions of contracting COVID-19 have been front-and-center for months. Beyond the disease’s physical effects, researchers say that its psychological toll may…
A Safer Dementia-Related Psychosis Treatment Grows Closer to FDA Approval
By
Alexandra Marvar
| July 31st, 2020
As many as half of the 45 million people worldwide who are living with Alzheimer’s will experience psychotic episodes, and that number is even…
5 Reasons The Pandemic Caused a Surge in Alzheimer’s Deaths
By
Alexandra Marvar
| July 14th, 2020
The National Center for Health Statistics attributes 266,000 deaths per year to Alzheimer’s and other forms of dementia. Upwards of 120,000 of those per…
Jason Karlawish: What is ‘ICU Delirium,’ and What Can Dementia Caregivers Do About It?
By
Tanner Jensen
| April 15th, 2020
As COVID-19 spreads, the risk of the elderly and people with dementia being hospitalized for the disease increases—not to mention all the other medical…
Phil’s Journal: How Caregivers Help People With Dementia Avoid Developing Delirium in the Hospital
By
Phil Gutis
| April 14th, 2020
A few years ago, I had a minor heart attack. I had persistent soreness in my upper left back and, on a whim, I…
Positive Results in Treating Dementia-Related Psychosis With Pimavanserin
By
Phil Gutis
| December 5th, 2019
nA highly anticipated Alzheimer’s conference opened here last night with reports about a powerful new drug for treating dementia-related delusions. ACADIA Pharmaceuticals presented its…
Antipsychotics Make No Difference for Delirium or Dementia in the I.C.U.
By
Being Patient
| October 22nd, 2018
A potent group of antipsychotic drugs used to treat delirium and dementia are not effective, according to a study published in the New England…